← Back to Search

Dietary Supplement

Extended Longevity Supplements for Aging

Phase 2
Waitlist Available
Research Sponsored by TruDiagnostic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up testing will compare the change in results after completion of intervention with baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a treatment plan called the Extended Longevity Protocol, which aims to slow down aging. It focuses on 15 healthy individuals to see if it can make them age more slowly and stay healthier. The protocol works by addressing nine different factors that contribute to aging.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~testing will compare the change in results after completion of intervention with baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and testing will compare the change in results after completion of intervention with baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Epigenetic Age

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExtractsExperimental Treatment1 Intervention
The ingredients found in these serums are all naturally occurring ingredients extracted from a variety of plant species: Pinetonal, Thyvolve, Telogenic, Sentophagy, Inflasolve, Stemegenis, and CMEnhance

Find a Location

Who is running the clinical trial?

TruDiagnosticLead Sponsor
11 Previous Clinical Trials
471 Total Patients Enrolled
8 Trials studying Aging
361 Patients Enrolled for Aging

Media Library

Extracts found in the Extended Longevity supplements (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05296993 — Phase 2
Aging Research Study Groups: Extracts
Aging Clinical Trial 2023: Extracts found in the Extended Longevity supplements Highlights & Side Effects. Trial Name: NCT05296993 — Phase 2
Extracts found in the Extended Longevity supplements (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05296993 — Phase 2
~3 spots leftby Oct 2025